James Hambro & Partners
- SEC CIK
- 0001731152
- Latest filing
- Jul 23, 2026
ABT holding history
Abbott Laboratories in every 13F filed by James Hambro & Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 19
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −2,190−100.0% | Sold out | Holders |
| Q1 2026 | 2,190 | $224.7K | <0.1% | +140+6.8% | Added | Holders |
| Q4 2025 | 2,050 | $256.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 2,050 | $274.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 2,050 | $278.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 2,050 | $271.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 2,050 | $231.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 2,050 | $233.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 2,050 | $213.0K | <0.1% | −121−5.6% | Reduced | Holders |
| Q1 2024 | 2,171 | $246.7K | <0.1% | +121+5.9% | Added | Holders |
| Q4 2023 | 2,050 | $225.7K | <0.1% | −1,000−32.8% | Reduced | Holders |
| Q3 2023 | 3,050 | $295.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 3,050 | $332.5K | <0.1% | −165−5.1% | Reduced | Holders |
| Q1 2023 | 3,215 | $325.5K | <0.1% | +1,015+46.1% | Added | Holders |
| Q4 2022 | 2,200 | $241.6K | <0.1% | +2,200 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −2,050−100.0% | Sold out | Holders |
| Q2 2022 | 2,050 | $223.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 2,050 | $243.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 2,050 | $289.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 2,050 | $242.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 2,050 | $238.0K | <0.1% | +2,050 | New | Holders |